جستجوی مقالات مرتبط با کلیدواژه "funding" در نشریات گروه "کتابداری و مدیریت اطلاعات"

Evaluating the success of policies and the reasons for their success or failure is an important part of the policy process. To assess the effectiveness of policy and program, it is necessary to specify the rationales and goals of the policy tools to be the basis for determining the evaluation criteria. A logic model by explaining the elements of a policy including resources, activities, outputs, short-medium- and long-term outcomes, and external impacts can be considered as the basis for the expected performance report of the programs. In this paper, first, the aims and rationales of fiscal and tax policy instruments are examined from a theoretical standpoint and based on a logic model. Then the law for supporting Knowledge-based firms (KBFs)is considered as a case study and the rationales of tax exemption and funding policy tools are presented on the basis of a logic model after analyzing the content of the relevant documents of this law and the interviews

Development of pharmaceutical industry in each country reflects its capabilities in the field of health care. Considering the progress of pharmaceutical industry and biotechnology in the same line and the role of biopharmaceuticals in the treatment of especial diseases in the societies, investigation of the commercialization process and determination of critical factors which accelerating the entrance the medicines to the market, is very crucial. The aim of this paper is to investigate different aspects of the drug commercialization process. The methodology of this research was based on literature review and deduction of related scientific papers and reports. The result of the research showed that one of the key factors in success of Iranian pharmaceutical companies is familiarity with various methods of funding appropriate to the stage of new medicine development. Likewise, the need for strategic alliances between large pharmaceutical companies and domestic startup biopharmaceutical companies with their foreign counterparts should be considered. Since there is not detailed information about innovations and new products developed by domestic companies, finally, proposed that the Food and Drug Administration of Iran or the Ministry of Health and Medical Education conduct an innovation survey in the pharmaceutical industry of the country.